About AKCA

Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals, Inc., is a biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. Akcea is advancing a mature pipeline of four novel drugs, including volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx, all with the potential to treat multiple diseases. All four drugs were discovered by and are being co-developed with Ionis, a leader in antisense therapeutics, and are based on Ionis proprietary antisense technology. The most advanced drug in its pipeline, volanesorsen, is under regulatory review in the U.S., EU and Canada for the treatment of familial chylomicronemia syndrome, or FCS, and is currently in Phase 3 clinical development for the treatment of familial partial lipodystrophy, or FPL. Akcea is building the infrastructure to commercialize its drugs globally with a focus on lipid specialists as the primary call point. Akcea is located in Cambridge, Massachusetts.
Primary Exchange: NASDAQ
SIC Biological Products, (No Diagnostic Substances)
NAICS Pharmaceutical Preparation Manufacturing

AKCA is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 247.9 M 2.47865E+08 234 234 0.16% 0.00158174 803 K 802652
UBIO Proshares UltraPro Nasdaq Biotechnology 31.1 M 3.10775E+07 228 228 0.09% 0.000918954 90 K 89998
URTY ProShares UltraPro Russell2000 105.8 M 1.05784E+08 2,016 2016 0.01% 5.19284E-05 17 K 17252
UWM ProShares Ultra Russell2000 184.1 M 1.84148E+08 2,016 2016 0.01% 6.95025E-05 28 K 28115
DWAQ Invesco DWA NASDAQ Momentum ETF 45.6 M 4.56E+07 100 100 0.61% 0.00612 273 K 272752
FPX First Trust US Equity Opportunities ETF 1.1 B 1.12216E+09 100 100 0.19% 0.0019 2.1 M 2132104
IBB iShares Nasdaq Biotechnology Index Fund 8.2 B 8.24908E+09 222 222 0.33% 0.0033 27.7 M 2.76514E+07
ITOT iShares Core S&P Total U.S. Stock Market ETF 18.7 B 1.87292E+10 3,568 3568 0.0% 0 115 K 114765
IWM iShares Russell 2000 ETF 44.9 B 4.48577E+10 2,006 2006 0.02% 0.0002 8.1 M 8073790
IWO iShares Russell 2000 Growth ETF 9.3 B 9.28872E+09 1,239 1239 0.04% 0.0004 3.2 M 3236400
IWV iShares Russell 3000 ETF 9.7 B 9.71954E+09 2,931 2931 0.0% 0 142 K 141960
LABU Direxion Daily S&P Biotech Bull 3X Shares 676.5 M 6.76479E+08 129 129 0.02% 0.000217959 533 K 532746
FHLC Fidelity MSCI Health Care Index ETF 1.6 B 1.6E+09 354 354 0.01% 0.00012581 201 K 201469
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.0 B 2E+09 1,005 1005 0.02% 0.000214828 424 K 423622

Wait, Before You Leave...